Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model
2011

How Breast Cancer Cells Share Drug Resistance

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jennifer Pasquier, Pierre Magal, Céline Boulangé-Lecomte, Glenn Webb, Frank Le Foll

Primary Institution: University of Le Havre

Hypothesis

Can P-glycoprotein transfer between breast cancer cells lead to acquired multidrug resistance?

Conclusion

The study confirmed that breast cancer cells can transfer P-glycoprotein to each other, which may contribute to drug resistance.

Supporting Evidence

  • Cell-to-cell transfers of P-glycoprotein were observed in co-cultures of resistant and sensitive breast cancer cells.
  • A mathematical model was developed to describe the dynamics of P-glycoprotein transfer.
  • Flow cytometry was used to analyze P-glycoprotein expression and efflux activity over time.

Takeaway

Breast cancer cells can share a protein that helps them resist drugs, making it harder to treat the cancer.

Methodology

The study used co-cultures of drug-resistant and sensitive breast cancer cells and a mathematical model to analyze P-glycoprotein transfer.

Limitations

The study primarily focused on in vitro conditions, which may not fully represent in vivo environments.

Participant Demographics

The study involved human breast cancer cell lines, specifically MCF-7 and MCF-7/Doxo.

Digital Object Identifier (DOI)

10.1186/1745-6150-6-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication